Shares of Swiss drugmaker Roche rallied on Wednesday after the company’s early-stage trial of an oral weight-loss drug showed it had promise.
The stock of 1-800-Flowers.com Inc. tumbled 3.4% early Wednesday, after D.A. Davidson downgraded it to underperform, or sell, from neutral, and said consensus estimates for its fiscal fourth quarter are looking too high.
Bank of America’s monthly survey of global fund managers found “geopolitical conflict,” as the most overriding concern for markets currently.
An unusually tranquil stretch for U.S. stocks is poised for a new milestone on Wednesday just as the rally appears to finally be broadening out beyond a handful of megacap names.
President Joe Biden and former President Donald Trump tag-teamed to hit microchip stocks on Wednesday, pressuring companies ranging from Advanced Micro Devices to Nvidia on worries over both Taiwan and China.
Nearly half of U.S. adults are struggling to cover the cost of prescription drugs and doctor visits, new research shows, marking a new low for healthcare affordability.
Johnson & Johnson’s stock seesawed into the red in early trading Wednesday, after the drugmaker beat second-quarter profit expectations but lowered its full-year outlook.
The U.S. stock market on average has done better when Congress is not in session.
